SUM159 cells treated with H3B-8800 or DMSO, Cytoplasmic fraction RNA-seq. SUM159 cells treated with H3B-8800 or DMSO, Cytoplasmic fraction RNA-seq
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
The objective is to identify splicing changes that occur after spliceosome inhibition in triple-negative breast cancer, specifically in cytoplasmic RNA. Overall design: SUM159 cells treated with H3B-8800 (spliceosome inhibitor) or vehicle (DMSO) for 12 hours in biological duplicate. RNA was isolated from the cytoplasm for downstream processing.
创建时间：
2020-12-15
